InnerCap - Compatibility

contact | privacy policy

Patent Pending US-2005-0008690-A1


Compound Enabling. Separates incompatible materials. Separates multiple-phased materials. Controlled timed-release profiles to separate release of incompatible materials. Controls chemical interactions between actives. Could increase number of new drugs brought to market. Allows different excipients used in single dosage form. HPMC, gelatin and alternative shell materials available.	High potency and low dose solutions. Protects biopharmaceuticals by increasing barriers. Water soluble and poorly soluble drugs delivered in single dosage form. Reduced migration associated with softgels. Finished product is less sensitive to heat than softgels. Provides means to administer combination therapies of pharmaceuticals and biopharmaceuticals. Improved drug content uniformity.

This photo shows how four individual compounds are
combined into one single dosage form. The combination dosage
form consists of a primary HPMC capsule containing an emulsion,
pH coated tablet, crystalline filled HPMC capsule and a beadlet
filled gelatin capsule.

Note: photo is enlarged to show components of delivery system.

Arachis Oil
Castor Oil
Coconut Oil

Soya Oil
Vitamin E
Vegetable Oil

Cottonseed Oil
Corn Oil
Olive Oil

MCT's
Palm Oil
Lipids